Diploma (LON:DPLM) Price Target Raised to GBX 7,500

Diploma (LON:DPLM) had its target price boosted by stock analysts at Berenberg Bank from GBX 6,600 to GBX 7,500 in a research report issued to clients and investors on Thursday,London Stock Exchange reports. The firm presently has a “buy” rating on the stock. Berenberg Bank’s price objective suggests a potential upside of 29.42% from the company’s current price.

Several other research analysts also recently weighed in on the company. Shore Capital Group restated a “hold” rating on shares of Diploma in a research note on Wednesday. Peel Hunt reissued a “buy” rating and issued a GBX 6,150 target price on shares of Diploma in a report on Friday, December 19th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Diploma from GBX 6,200 to GBX 6,400 and gave the stock a “buy” rating in a research report on Thursday. Stifel Nicolaus lifted their price target on shares of Diploma from GBX 6,200 to GBX 6,800 and gave the company a “buy” rating in a report on Thursday. Finally, Royal Bank Of Canada boosted their price target on shares of Diploma from GBX 6,200 to GBX 6,600 and gave the stock an “outperform” rating in a research note on Thursday. Five analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Diploma has an average rating of “Moderate Buy” and an average target price of GBX 6,023.75.

Diploma Price Performance

Shares of LON:DPLM traded down GBX 130 during trading on Thursday, hitting GBX 5,795. 38,388,117 shares of the company’s stock were exchanged, compared to its average volume of 2,353,902. The business’s 50-day simple moving average is GBX 5,451.05 and its 200 day simple moving average is GBX 5,421.27. The company has a market cap of £7.77 billion, a price-to-earnings ratio of 42.21, a PEG ratio of 2.82 and a beta of 1.03. Diploma has a 52-week low of GBX 3,532 and a 52-week high of GBX 6,019.52. The company has a debt-to-equity ratio of 46.97, a current ratio of 2.04 and a quick ratio of 0.80.

Insider Buying and Selling at Diploma

In related news, insider Ian El-Mokadem purchased 500 shares of the company’s stock in a transaction that occurred on Wednesday, January 14th. The stock was bought at an average price of GBX 5,615 per share, for a total transaction of £28,075. Also, insider Johnny Thomson sold 30,000 shares of the business’s stock in a transaction that occurred on Friday, January 16th. The stock was sold at an average price of GBX 5,668, for a total value of £1,700,400. Insiders bought a total of 1,262 shares of company stock worth $6,995,830 in the last 90 days. 1.14% of the stock is currently owned by insiders.

Diploma News Roundup

Here are the key news stories impacting Diploma this week:

• Positive Sentiment: Management upgraded FY2026 guidance after a strong first half — the outlook upgrade was described as “significant” and cited resilient aerospace demand as a driver. Read More.
• Positive Sentiment: Market reaction: several outlets report shares surged (up as much as ~17%) after the profit/guidance upgrade, showing the news materially raised investor expectations. Read More.
• Positive Sentiment: Analyst actions: Royal Bank of Canada raised its price target from 6,200p to 6,600p and moved to an “Outperform” rating. Read More., Read More.
• Positive Sentiment: Analyst actions: Stifel Nicolaus lifted its target from 6,200p to 6,800p and put a “Buy” on the stock — adding upward pressure on valuation. Read More.
• Neutral Sentiment: Some brokers remain cautious: Shore Capital reaffirmed a “Hold” rating, tempering unanimity of the buy-side upgrades. Read More., Read More.
• Negative Sentiment: Intraday selling/profit‑taking: after the sharp rally on guidance and upgraded forecasts, the stock pulled back amid very heavy volume (well above average), suggesting short‑term profit taking and volatility even though the fundamental outlook was upgraded. Read More.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.